Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases - Wikidata - awgldk - TriplyDB

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

http://www.wikidata.org/entity/Q24650014

about

Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's Disease Molecular Mechanism of Adult Neurogenesis and its Association with Human Brain Diseases Alzheimer's pathogenesis and its link to the mitochondrion The relationship between amyloid structure and cytotoxicity Protein Oxidation in Aging: Does It Play a Role in Aging Progression?A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?Bacterial amyloid formation: structural insights into curli biogensis A molecular analysis of desiccation tolerance mechanisms in the anhydrobiotic nematode Panagrolaimus superbus using expressed sequenced tags.Toxic fibrillar oligomers of amyloid-β have cross-β structure.Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.Estradiol prevents olfactory dysfunction induced by A-β 25-35 injection in hippocampus.Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders.Positron emission tomography radioligands for in vivo imaging of Aβ plaques.Evaluating nuclei concentration in amyloid fibrillation reactions using back-calculation approach.Immunological detection of N-formylkynurenine in oxidized proteins.Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism.Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration.The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.Cerebrospinal fluid biomarkers for dementia with lewy bodies.Mechanisms for the Insertion of Toxic, Fibril-like β-Amyloid Oligomers into the Membrane.Macroautophagy is not directly involved in the metabolism of amyloid precursor protein.Single-channel electrophysiology reveals a distinct and uniform pore complex formed by α-synuclein oligomers in lipid membranes A relationship between the transient structure in the monomeric state and the aggregation propensities of α-synuclein and β-synuclein Spectroscopic Characterization of Intermolecular Interaction of Amyloid β Promoted on GM1 Micelles.Genetics of Alzheimer disease Metabolic states following accumulation of intracellular aggregates: implications for neurodegenerative diseases.Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide.Sumoylation inhibits alpha-synuclein aggregation and toxicity.Human serum transferrin fibrils: nanomineralisation in bacteria and destruction of red blood cells.Intracellular screening of a peptide library to derive a potent peptide inhibitor of α-synuclein aggregation.Magmas functions as a ROS regulator and provides cytoprotection against oxidative stress-mediated damages Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.Oxidative stress in aging human skin.

P2860

Q24630045-48D9FE95-DAD2-4ECB-94F3-4D71CF74B0D8 Q26738355-C32E8FCE-5712-406C-B6BF-071A0216B51E Q26738450-D0D73AAC-D9AB-4533-AE2B-2446104A2334 Q26745434-E8979759-D5C8-42D6-B76C-09BDFB0EF4D2 Q27000255-AA85CB62-6CFC-430A-ACB2-6B33C9622CC7 Q27012641-0BB5B08F-FCF8-496E-BD1B-AC4E22403BAA Q27021668-36E52FD7-C1D6-4A6C-B5F7-C851AEA29839 Q28078724-1CBF0B54-CE00-49EE-913B-E6A61EBB607C Q28082740-24A5C0C4-0346-4FA4-998F-6AD831F87761 Q30506753-97CF6377-B36D-4106-8CC3-9B30E682CEA3 Q30514124-7DE23328-A72B-4D93-8A1A-CE04A3FFFD37 Q30540027-06D13404-EA6C-407C-A6C1-094650249246 Q31140077-FB092209-BD61-496F-88B0-49CC6F13384C Q33517630-84DB7898-8811-4692-9D35-E2E86DAAAE9E Q33838788-1535A790-71BA-4754-A5C6-1E6AFA50E33C Q33874024-46D4D279-65CF-4A8B-9F5B-453285422CA4 Q33916291-7EC3C6F4-86AB-4C9F-8467-D983719157B0 Q33940299-44C94A13-5442-4F7D-809C-FE7FE1AC33B5 Q33947949-04B8435A-29E5-4120-A7E2-0A8512B83CD0 Q34003885-9DD3B325-506F-4A84-BEF5-695A6F513D92 Q34020622-92921991-6221-497E-B25E-259EE1C9C43E Q34048835-FF199479-BF31-4EE6-97AF-FBDEA255D58F Q34111497-E806C4F2-84C4-4524-9FC6-CBEDE1E29CD6 Q34207247-0C0D130A-26BC-4F69-8074-CD50FB3AFFD1 Q34242682-A9DA9173-32B5-4582-8A4A-3A8A3F2E5AEA Q34248241-7B543798-FB18-4760-821C-521CFB2FE337 Q34322404-24E7DF39-7E91-4811-8EA1-9B5EA9308561 Q34333621-62FF6A07-5875-4456-8ECB-6CBA41A0A96A Q34374310-DFADED50-8739-461F-BFAB-55E4D0C3B421 Q34447530-C7E01B4F-2B69-4083-9F1C-0BA70300FD8C Q34557355-425D0465-685D-42F0-BF96-8ABB62ECF66D Q34604101-17D9F2EA-CC66-4D2D-B436-2ABF0D77CD5D Q34718426-DBE8FA2A-3E65-4AA3-92B3-9BD989BCC1DD Q35083908-59406DF9-DBDF-47F9-AD59-06D41B498997 Q35102441-154E569F-87B6-4399-9309-F27488E77F3B Q35211683-1A1808AD-8D35-44DE-8983-AA4920A06CE7 Q35548280-3521161E-2B32-49DF-B8B4-273A82185458 Q35679575-6AFF1545-7ADE-4A39-867A-A2D43BB1F2E7 Q35776066-4AC1F1C6-8F83-4FBC-8878-CFF8F7679300 Q35833994-1A79D630-6EB0-478E-A7E0-CB1CE75A8CD0

P2860

Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases

http://www.wikidata.org/entity/Q24650014

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@ast

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@en

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@nl

type

label

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@ast

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@en

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@nl

prefLabel

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@ast

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@en

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@nl

P1433

Q24650014-6D1F99F8-154B-4244-BBD5-5C31F3FDEE6A

P1476

Q24650014-2E33ED06-167A-440C-9A72-291EF73E3351

P2093

Q24650014-3AF9C2E7-6B23-4F82-97A3-BE7462A850AB

Q24650014-6CE776EE-E967-44D6-A207-F61482496FDC

Q24650014-92F659DD-D8E5-4B66-A4CA-561A89174D3E

Q24650014-DDE345D8-0228-4B5A-9D09-B38000981B16

P2860

Q24650014-0389C92E-E514-4324-8075-751CE7621D35

Q24650014-046B5B39-EE8B-413A-9501-BDC277A924B4

Q24650014-046DF338-00FF-4E6E-98FB-CDBD25E10B5A

Q24650014-048B0558-997B-4241-8EA1-2905389A276D

Q24650014-05BE14BB-8656-465F-BD0C-1FD32E043C0A

Q24650014-06F6D281-1011-4F4F-BD68-5941CE2C35CE

Q24650014-07103E91-1F6B-4DBB-AD0F-D91E533AFC9C

Q24650014-0A86F075-3A3C-445B-92EB-B13D7318DAEA

Q24650014-0C263DC8-4189-4C2B-89EF-8082D0CE42C0

Q24650014-0CCE5F9C-369B-4595-92FA-5D0E01741352

P2888

Q24650014-6A95FCB7-6F55-45D9-9CC7-2A907AC79339

P304

Q24650014-580CF47A-1BC7-4B60-AF73-91BD9F4BC8D2

P31

Q24650014-057ADB88-BC67-47FC-90E6-42F607BDB3D2

P3181

Q24650014-FBCC9C1B-ADA3-46B4-A499-BDC31EED2027

P356

Q24650014-E301D10E-68BB-40EB-86A5-A0BD75085FF7

P407

Q24650014-DC723914-5DF2-4D73-9CE8-8624E31E89D8

P433

Q24650014-6960E752-9123-4F75-BC5B-76C20BA69E33

P478

Q24650014-4FBA7077-4400-4EAE-9B2D-7B841734C850

P577

Q24650014-0DA76BD2-C76D-4709-988A-2151EA3CDFA4

P6179

Q24650014-B6FAEBE5-9D66-4B31-B5B5-855E8167C633

P698

Q24650014-DB8A9A35-F809-4E56-9756-44536304A670

P921

Q24650014-71B36D2C-A7B1-452D-9E93-D783F44A218C

Q24650014-CB0218D4-729F-48D9-B4F4-0B57AE584C4B

Q24650014-EBC8DF67-C17E-435F-978D-37EA73BFDAD3

P932

Q24650014-B55D5DC9-928A-4FCE-9D24-D3A20071C638

P3181

P356

2007-00100.IRVINE

P1433

Molecular Medicine

P1476

Protein aggregation in the bra ...... mer's and Parkinson's diseases

@en

P2093

Dominic M Walsh

http://www.w3.org/2001/XMLSchema#string

G Brent Irvine

http://www.w3.org/2001/XMLSchema#string

Ganesh M Shankar

http://www.w3.org/2001/XMLSchema#string

Omar M El-Agnaf

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Role of Genes and Environments for Explaining Alzheimer Disease

Molecular markers of early Parkinson's disease based on gene expression in blood

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Global prevalence of dementia: a Delphi consensus study

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

P2888

2007-00100.irvine

P304

451-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

397847

http://www.w3.org/2001/XMLSchema#string

P356

10.2119/2007-00100.IRVINE

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1068965042

http://www.w3.org/2001/XMLSchema#string

P698

18368143

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Parkinson's disease

P932

2274891

http://www.w3.org/2001/XMLSchema#string